NAC vs L-Cysteine: Which Is Better for Liver Support?

NAC and L-cysteine are two different ways to deliver cysteine — the amino acid the body uses to make glutathione, the liver’s main antioxidant. They are closely related but not identical, and they differ most in their regulatory status. This is a neutral comparison of the two ingredients, not medical advice, and neither is part of Hovenia (more on that below).

These statements have not been evaluated by the Food and Drug Administration or Health Canada. This product is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before use.

The Short Answer

Both NAC (N-acetyl cysteine) and L-cysteine are cysteine sources, and cysteine is the rate-limiting building block the body uses to synthesize glutathione. The practical differences:

NAC has an acetyl group that tends to improve its stability and absorption, and a long history of pharmaceutical use.
L-cysteine is the plain free amino acid, with an unambiguous status as a dietary supplement and Natural Health Product ingredient.

The performance gap at common supplement doses is modest. The regulatory gap is the more consequential difference — and that’s the part most comparisons skip.

One thing to clear up first: Hovenia is single-ingredient pure DHM (dihydromyricetin) — it does not contain NAC or L-cysteine. This article is category education about two glutathione-precursor ingredients you’ll see in other liver formulas, not a description of what’s in our bottle.

What Glutathione Does (and Why Cysteine Matters)

Glutathione (specifically reduced glutathione, GSH) is a tripeptide — three amino acids linked together: glycine, glutamate, and cysteine. The liver synthesizes it continuously and uses it as a primary antioxidant.

Of those three amino acids, cysteine is the rate-limiting one — glutathione synthesis tends to be constrained by how much cysteine is available, not glycine or glutamate. That’s why both NAC and L-cysteine are studied as glutathione “precursors”: they supply the building block that’s usually in shortest supply.

Glutathione itself is poorly absorbed when taken orally, which is why supplementation strategies generally focus on supplying precursors the liver can use to make its own, rather than glutathione directly. The body’s handling of alcohol is a two-step process — alcohol is metabolized to acetaldehyde, then acetaldehyde to acetate — and glutathione is among the systems involved in managing the oxidative byproducts of that process. This is biology, not a claim about any product.

N-Acetyl Cysteine (NAC)

NAC is cysteine with an acetyl group attached to the nitrogen. That modification is associated with two practical differences:

Absorption. The acetyl group tends to make NAC more stable in the gut and less prone to oxidation before absorption than free cysteine. Researchers generally describe its oral bioavailability as better than plain cysteine, though published absolute figures vary.
Direct antioxidant activity. NAC has been studied as a free-radical scavenger in its own right, independent of its role as a glutathione precursor.

NAC also has a long medical history: it is used in hospitals as the standard treatment for acetaminophen (paracetamol) overdose, where it is given to restore hepatic glutathione, and it has decades of use in respiratory medicine as a mucolytic (trade name Mucomyst). That pharmaceutical pedigree is real — and, as the next section explains, it’s also the source of NAC’s regulatory complications.

The NAC regulatory situation (stated factually)

NAC as a supplement ingredient has had genuine regulatory back-and-forth in the United States. In 2020, the FDA sent warning letters to several companies marketing NAC-containing supplements, taking the position that because NAC was approved as a drug before it was marketed as a supplement, it is excluded from the dietary-supplement definition under the relevant provision of DSHEA. The agency’s stance subsequently softened: in 2022 the FDA issued guidance saying it intended to use enforcement discretion for NAC sold as a supplement while it considered whether to allow it by rule.

The net effect, stated neutrally: NAC supplements remain widely sold, but the ingredient’s supplement status has been the subject of unresolved regulatory disagreement rather than a settled question. In Canada, NAC is handled through the Natural Health Products framework, and its pharmaceutical history can mean additional scrutiny for products that use it as a primary ingredient.

None of this is a safety judgment — it’s a regulatory-status fact, and it’s the single clearest difference between the two ingredients.

L-Cysteine

L-cysteine is the free amino acid form of cysteine. It is generally described as a conditionally essential amino acid: the body can make it from methionine under normal conditions, but demand can exceed supply under metabolic stress.

Absorption. The historical concern with free L-cysteine was that it can oxidize to cystine in the gut and that very high concentrations of free cysteine may act as a pro-oxidant. At the doses typically used in liver-support formulations (roughly 200–600 mg), L-cysteine is generally regarded as well tolerated, though it is often considered a less efficient cysteine-delivery route than NAC on a milligram-for-milligram basis.

Regulatory status. This is L-cysteine’s main advantage. It is treated unambiguously as a dietary-supplement ingredient in the US and is listed in Health Canada’s Natural Health Products Ingredients Database (NHPID). It carries no pharmaceutical-drug exclusion history of the kind that has complicated NAC. For a product pursuing a Canadian NPN, that clean status is meaningful.

Direct Comparison

	NAC (N-Acetyl Cysteine)	L-Cysteine
What it is	Acetylated cysteine	Free-form cysteine amino acid
Role	Glutathione precursor; also studied as a direct antioxidant	Glutathione precursor
Absorption	Generally described as better; acetyl group improves stability	Generally lower; can oxidize in the gut
Medical history	Extensive (acetaminophen overdose, mucolytic)	No pharmaceutical-drug history
US supplement status	Subject of FDA back-and-forth (2020 warning letters; 2022 enforcement-discretion guidance)	Unambiguous dietary-supplement ingredient
Canadian NHP status	Can attract extra scrutiny via pharmaceutical history	Listed in the NHPID
Typical supplement dose	~600–1,800 mg/day in studies	~200–600 mg/day in formulations
Safety note (general)	Generally regarded as safe; very high doses studied as pro-oxidant	Generally regarded as safe; high doses can be pro-oxidant

Read the table as differences, not as a verdict that one ingredient is more effective. At the doses used in everyday supplements, head-to-head efficacy differences for raising glutathione are generally reported as modest.

Where Hovenia Fits (It Doesn’t Use Either)

It’s worth being explicit, because the rest of this article is about two ingredients Hovenia does not contain.

Hovenia is single-ingredient pure DHM (dihydromyricetin) — 1,000 mg per serving, nothing else. No NAC, no L-cysteine, no proprietary blend. DHM is a flavonoid from Hovenia dulcis (the Oriental Raisin Tree), and it works through a different line of research than the glutathione-precursor amino acids discussed here.

That’s a deliberate difference, not an oversight. Many recovery and liver-support products are multi-ingredient blends that stack DHM together with cysteine sources, milk thistle, B-vitamins, and electrolytes. Hovenia takes the opposite approach: one studied compound at a full dose, so you can see exactly what you’re taking. Whether a blend or a single ingredient suits you is a personal call — this comparison is here so you can read a NAC-vs-L-cysteine label honestly, not because either is in our formula.

If you want to understand the glutathione-precursor side in more depth, see our explainer on L-cysteine and the liver’s glutathione system. For what DHM itself actually is, start with what is DHM.

How These Show Up in Liver Formulas

If you’re comparing products on a shelf rather than building a personal stack, here’s the practical read:

A Canadian product pursuing an NPN has a clear incentive to choose L-cysteine, because its regulatory status is settled. That choice tells you something about the brand’s compliance posture, not necessarily about potency.
A US product unconcerned with the NAC question may use NAC for its absorption profile and broader research base.
A single-ingredient product (like Hovenia) sidesteps the question entirely by not including a cysteine source at all.

There’s no universally “better” answer — the right ingredient depends on the goal, the market, and the regulatory framework the product is built for.

Frequently Asked Questions

Is NAC or L-cysteine better for raising glutathione? Both supply cysteine, the rate-limiting building block for glutathione. NAC is generally described as the more efficiently absorbed of the two on a milligram-for-milligram basis, but at common supplement doses the difference reported in the literature is modest. The bigger practical distinction is regulatory, not performance.

Is NAC banned or illegal as a supplement? No. NAC supplements remain widely available. What happened is that the FDA sent warning letters in 2020 questioning NAC’s supplement status because of its prior approval as a drug, then issued guidance in 2022 indicating it intended to exercise enforcement discretion while it reviewed the issue. The status has been disputed and unresolved rather than settled — that’s a regulatory fact, not a safety warning.

Does Hovenia contain NAC or L-cysteine? No. Hovenia is single-ingredient pure DHM (dihydromyricetin), 1,000 mg per serving, with nothing else added. This article compares two ingredients you’ll find in other formulas; it isn’t a description of ours.

Can you take glutathione directly instead? Oral glutathione is generally considered poorly absorbed, which is why precursor strategies focus on supplying cysteine for the body to build its own. Discuss any supplement plan with a healthcare provider, especially if you take medication or have a liver condition.

Which should a Canadian brand choose? For a product seeking a Health Canada NPN, L-cysteine’s listed status in the NHPID makes it the lower-friction choice. NAC’s pharmaceutical history can add scrutiny. That’s a compliance consideration, not a statement that one ingredient outperforms the other.